Shuqun Cheng
- Hepatology top 0.2%
- Molecular Biology top 5%
- Epidemiology top 2%
- Cancer Research top 1%
- Surgery top 5%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (90 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (48 papers)Liver Disease Diagnosis and Treatment (30 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Shuqun Cheng
193 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Hepatology 2.5k
- Molecular Biology 1.7k
- Epidemiology 1.4k
- Cancer Research 1.4k
- Surgery 852
Countries citing papers authored by Shuqun Cheng
This map shows the geographic impact of Shuqun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqun Cheng more than expected).
Fields of papers citing papers by Shuqun Cheng
This network shows the impact of papers produced by Shuqun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqun Cheng. The network helps show where Shuqun Cheng may publish in the future.
Co-authorship network of co-authors of Shuqun Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Shuqun Cheng. A scholar is included among the top collaborators of Shuqun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqun Cheng. Shuqun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 7 | |
| 7 | 41 | |
| 8 | 10 | |
| 9 | 57 | |
| 10 | 17 | |
| 11 | 56 | |
| 12 | 14 | |
| 13 | 85 | |
| 14 | 40 | |
| 15 | 21 | |
| 16 | 21 | |
| 17 | 17 | |
| 18 | 3 | |
| 19 | 8 | |
| 20 | 84 |
About Shuqun Cheng
Shuqun Cheng is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 202 papers that have together received 5.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (90 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (48 papers) and Liver Disease Diagnosis and Treatment (30 papers). The work is most often cited by research in Hepatology (2.5k citations), Cancer Research (1.4k citations) and Epidemiology (1.4k citations). Shuqun Cheng has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Wei‐Xing Guo, Jie Shi, Wan Yee Lau, Mengchao Wu, Xiuping Zhang, Jie Xue, Chengzhi Chen, Kang Wang, Dong Xie and Baijie Tu. Their work appears in journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.